featured
Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Tumor Mutational Burden, Toxicity and Response of Immune Checkpoint Inhibitors (ICIs) Targeting PD(L)1, CTLA-4, and Combination: A Meta-Regression Analysis
Clin. Cancer Res 2020 Jun 25;[EPub Ahead of Print], A Osipov, SJ Lim, A Popovic, NS Azad, DA Laheru, L Zheng, EM Jaffee, H Wang, M YarchoanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.